# DYMISTA

NDC: 0037-0245
Generic name: Azelastine Hydrochloride and Fluticasone Propionate
Labeler / Manufacturer: Viatris Specialty LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SPRAY, METERED
Routes: NASAL
Marketing started: 20161001

FDA application: NDA202236

## Active ingredients

- AZELASTINE HYDROCHLORIDE: 137 ug/1
- FLUTICASONE PROPIONATE: 50 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0037-0245"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0037-0245
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c557ec4-c4cf-11df-851a-0800200c9a66